Want to see TSE:ENBI.X full AI Analyst Report?
Entheon Biomedical (ENBI.X) Stock Statistics & Valuation Metrics
Total Valuation
Entheon Biomedical has a market cap or net worth of CAD 762.24K. The enterprise value is CAD 1.06M.
- Market Cap
- CAD 762.24K
- Enterprise Value
- CAD 1.06M
Share Statistics
Entheon Biomedical has 13,858,926 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 13,858,926
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Entheon Biomedical’s return on equity (ROE) is -1.00 and return on invested capital (ROIC) is -103.15%.
- Return on Equity (ROE)
- -1.00
- Return on Assets (ROA)
- -0.92
- Return on Invested Capital (ROIC)
- -103.15%
- Return on Capital Employed (ROCE)
- -1.03
- Revenue Per Employee
- 0
- Profits Per Employee
- -324.01K
- Employee Count
- 1
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Entheon Biomedical is -4.27. Entheon Biomedical’s PEG ratio is -0.08.
- PE Ratio
- -4.27
- PS Ratio
- 0.00
- PB Ratio
- 4.28
- Price to FCF
- -4.40
- Price to Operating Cash Flow
- -4.40
- PEG Ratio
- -0.08
Income Statement
In the last 12 months, Entheon Biomedical had revenue of 0 and earned -324.01K in profits. Earnings per share was -0.02.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -334.22K
- Pretax Income
- -324.01K
- Net Income
- -324.01K
- EBITDA
- -334.22K
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -314.66K and capital expenditures 0, giving a free cash flow of -314.66K billion.
- Operating Cash Flow
- -314.66K
- Free Cash Flow
- -314.66K
- Free Cash Flow per Share
- -0.02
Dividends & Yields
Entheon Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -22.70%
- Earnings Yield
- -23.42%
Stock Price Statistics
- Beta
- 1.82
- 52-Week Price Change
- -42.11%
- 50-Day Moving Average
- 0.06
- 200-Day Moving Average
- 0.08
- Relative Strength Index (RSI)
- 45.38
- Average Volume (3m)
- 29.32K
Important Dates
Entheon Biomedical upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 22, 2026
- Next Earnings Date
- Mar 30, 2027
- Ex-Dividend Date
- ―
Financial Position
Entheon Biomedical as a current ratio of 11.72, with Debt / Equity ratio of 0.00%
- Current Ratio
- 11.72
- Quick Ratio
- 11.72
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.96
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Entheon Biomedical has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Entheon Biomedical EV to EBITDA ratio is -3.78, with an EV/FCF ratio of -3.38.
- EV to Sales
- 0.00
- EV to EBITDA
- -3.78
- EV to Free Cash Flow
- -3.38
- EV to Operating Cash Flow
- -3.38
Balance Sheet
Entheon Biomedical has CAD 321.83K in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of CAD 321.83K billion.
- Cash & Marketable Securities
- CAD 321.83K
- Total Debt
- CAD 0.00
- Net Cash
- CAD 321.83K
- Net Cash Per Share
- CAD 0.02
- Tangible Book Value Per Share
- CAD 0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Scores
- Smart Score
- ―
- AI Score
- 44
